Clinical Trial Looks at Effectiveness of New Neurotoxin, DAXXIFY, for Spasmodic Dysphonia
New clinical trial evaluates the safety of DAXXIFY and compares the treatment response to botulinum toxin A in patients with adductor spasmodic dysphonia.
New clinical trial evaluates the safety of DAXXIFY and compares the treatment response to botulinum toxin A in patients with adductor spasmodic dysphonia.
Join us in-person for the 2023 Dysphonia International Symposium on April 29, 2023, in the Detroit area.
It is with great sorrow that we share that NSDA Founding President Larry Kolasa passed away. We honor his legacy and commitment to our community.
GUEST SPEAKER PROGRAM FOR SLP STUDENTS The Guest Speaker Program for Speech-Language Pathology (SLP) Students is an outreach program sponsored by Dysphonia International that brings the personal side of living…
Singer Jimmie Rodgers passed away. He served as an NSDA Honorary Director and was the Keynote Speaker at 2005 NSDA Symposium. Jimmie had a string of hits in the 50s and 60s including, Honeycomb and Kisses Sweeter than Wine, until spasmodic dysphonia took his singing voice away.
READ MOREREAD THE 2023 HIGHLIGHTSSAVE THE DATE | OCTOBER 17-20, 2024CLICK HEREWATCH HERE Previous slide Next slide You did not cause this.Friends and family members may be questioning you. You…
2020 Issue of "Our Voice" Our Voice is the newsletter of the National Spasmodic Dysphonia Association that is published annually. This issue was published in October 2020. The theme of…
Having a voice disorder can be challenging, but having to wear a mask can make it even harder with the additional effort to project your voice. With these awareness masks, you can let people know that you have a voice disorder without having to say a word.